Fulgent Genetics, Inc.
FLGT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001674930
In the last 90 days, Fulgent Genetics, Inc. insiders filed 0 open-market purchases and 4 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $321.8M in total; no superinvestor holds it.
Superinvestors holding FLGT, Q2 2026
No superinvestor reported holding FLGT in Q2 2026.